Atipamezole is a potent and highly specific antagonist of centrally and peripherally located α2-adrenoceptors and has approximately 100 times more affinity than yohimbine at the α2D-adrenoceptors.
Recommended dose for reversal is 50 - 300 μg/kg.
- Virtanen R (1989) Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand Suppl 85:29–37
- Andrade SF &Sakate M (2003) The comparative efficacy of yohimbine and atipamezole to treat amitraz intoxication in dogs. Vet Hum Toxicol 45(3):124-127
- Ko JC et al (2013) Influence of ketamine on the cardiopulmonary effects of intramuscular administration of dexmedetomidine-buprenorphine with subsequent reversal with atipamezole in dogs. J Am Vet Med Assoc 242(3):339-345